ISSN:
1440-1797
Source:
Blackwell Publishing Journal Backfiles 1879-2005
Topics:
Medicine
Notes:
SUMMARY: Simplicity and sufficiency in the management of renal anaemia were first envisaged with the development and production of recombinant human erythropoietin (epoetin). Recent years, however, have seen the publication of several studies examining the optimal administration of epoetin, the emergence of a new erythropoietic agent (Novel Erythropoietic Stimulating Protein, NESP), recognition of the need for supraphysiological iron levels, and the possible use of many potential adjuvant agents. Together, these factors have made the management of renal anaemia substantially more complex, perhaps even to the point of confusion. the purpose of this review, therefore, is to examine the evidence relating to these factors in order to offer a summary of their known effects on anaemia management, hopefully with some progress towards the initial goals.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1046/j.1440-1797.2002.00092.x
